fda glp-1 warning news november 2025 The has received hundreds of adverse event reports tied to compounded GLP-1s. PRI's brief warns that patients should know the risks before trusting knockoff versions. Read the brief: https://medecon.org/unauthorized-glp-1-knockoffs/ Q1 2026 in Review: Milsaperidone,
Description
Learn about cannabis and Wegovy, potential side effects, appetite changes, and safety considerations.
While positive for consumers, it places significant financial pressure on an already brittle healthcare and Medicare ecosystem
The 2026 Math Flip: Brand name can be cheaper than compounded tirzepatide
When I compare GLP-1 prices across different brands, I notice significant variations that can really impact my wallet
